Efavirenz-induced photoallergic dermatitis in HIV.
Treudler
R
R
Husak
R
R
Raisova
M
M
Orfanos
C E
CE
Tebbe
B
B
D000368:Aged; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D048588:Benzoxazines; D003521:Cyclopropanes; D017454:Dermatitis, Photoallergic / Q000175:diagnosis* / Q000209:etiology; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010078:Oxazines / Q000009:adverse effects* / Q000627:therapeutic use; D010641:Phenotype; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz